Diagnostic Imaging Radiation: How Much of a Clinical Issue?

Sunday, April 3, 8:00-9:30 AM

The issue of radiation dose associated with diagnostic imaging can be challenging to clinicians. In this session, attendees will hear from a physicist and a representative from the FDA in what promises to be an interesting view from the technical and regulatory perspective. Clinicians also will discuss risk/benefits associated with imaging with an interesting twist.

Speaker Information
  • Kevin L. Nelson, PhD, Mayo Clinic, Jacksonville, Fla. -- Diagnostic Imaging Radiation: How Much of a Clinical Issue? View of the Physicist
  • Orhan H. Suleiman, PhD, FDA's Center for Drug Evaluation and Research, Rockville, Md. -- Diagnostic Imaging Radiation Exposure: View of a Regulatory Agency
  • Rita F. Redberg, MD, University of California, San Francisco -- Assessing Risk in the Face of Benefit
  • Jack A. Ziffer, MD, PhD, Miami Cardiac and Vascular Institute, Miami -- Assessing Benefit in the Face of Risk

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.